Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Kraig Biocraft Laboratories (KBLB) FCF Margin (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed FCF Margin for 6 consecutive years, with 596.34% as the latest value for Q4 2022.

  • Quarterly FCF Margin rose 103155384.0% to 596.34% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 309.82% through Dec 2022, down 28584.0% year-over-year, with the annual reading at 484.6% for FY2025, 13654.0% up from the prior year.
  • FCF Margin hit 596.34% in Q4 2022 for Kraig Biocraft Laboratories, down from 649.47% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 649.47% in Q3 2022 to a low of 1030957.5% in Q4 2021.
  • Historically, FCF Margin has averaged 102880.33% across 3 years, with a median of 216.86% in 2022.
  • Biggest YoY gain for FCF Margin was 103155384bps in 2022; the steepest drop was -2532bps in 2022.
  • Year by year, FCF Margin stood at 22.8% in 2018, then tumbled by -4521292bps to 1030957.5% in 2021, then skyrocketed by 100bps to 596.34% in 2022.
  • Business Quant data shows FCF Margin for KBLB at 596.34% in Q4 2022, 649.47% in Q3 2022, and 161.11% in Q2 2022.